Assisted reproductive technology

CCRM FERTILITY WELCOMES REGIONAL DIRECTOR OF CLINICAL REPRODUCTIVE GENETICS, DR. JASMINE ALY, TO JERSEY CITY TEAM

Retrieved on: 
Wednesday, March 27, 2024
ART, WRNMMC, Obstetrics, PCOS, Gynaecology, Obesity, Polycystic disease, Reproductive Sciences, Science, NHGRI, Genetic distance, FACOG, Genetics, COVID-19, Patient, Empathy, Medical genetics, Cooper University Hospital, Research, African Americans, USUHS, Fibroid, Reproduction, Assisted reproductive technology, IRMS, NIH, Polycystic ovary syndrome, Outline of health sciences, Reproductive endocrinology and infertility, Publication, Fertility, REI, Birth control

JERSEY CITY, N.J., March 27, 2024 /PRNewswire/ -- CCRM Fertility, a leading pioneer in the fertility treatment, research, and science industry, announced today that Jasmine Aly, MD, FACOG, will be joining  CCRM | IRMS in New Jersey. Dr. Aly holds the rare distinction of being a triple-specialized physician as an Obstetrician-Gynecologist, Reproductive Endocrinologist, and Medical Geneticist.

Key Points: 
  • JERSEY CITY, N.J., March 27, 2024 /PRNewswire/ -- CCRM Fertility, a leading pioneer in the fertility treatment, research, and science industry, announced today that Jasmine Aly, MD, FACOG, will be joining  CCRM | IRMS in New Jersey.
  • As Regional Director of Clinical Reproductive Genetics, Dr. Aly will bring her expertise to the CCRM Fertility team and aims to leverage her comprehensive fellowship training in genetics to further advance the field and better serve patients.
  • As an esteemed reproductive endocrinologist, she will utilize cutting-edge  technology and innovative scientific techniques to ensure patient success rates continue to rise.
  • "Dr. Aly's expertise in genetics is an invaluable attribute that will redefine care at CCRM | IRMS," notes CCRM Fertility CEO, Bob LaGalia.

JOURNALIST AND INFERTILE AF PODCAST HOST ALI PRATO WRITES CHILDREN'S BOOK ABOUT IVF, "WORK OF ART" - OUT TODAY

Retrieved on: 
Tuesday, March 5, 2024
Love, NBA, Basketball, Assisted reproductive technology, IVF, Fertility, INFO, ART, Infertility, Family, Child, Science, HERE, Birth control

MAPLEWOOD, N.J., March 5, 2024 /PRNewswire/ -- Ali Prato, journalist, Fertility Rally co-founder and Infertile AF podcast host, has written a groundbreaking children's book about IVF and family building through Assisted Reproductive Technology (ART), published today. 

Key Points: 
  • Ali Prato, host of Infertile AF podcast wrote a children's book about IVF and Assisted Reproductive Technology out now.
  • Ali is an infertility warrior and advocate who went through secondary infertility before having her second child, Sonny, through IVF.
  • Ali's podcast, Infertile AF, founded in 2019, has released more than 260 episodes and has been downloaded globally more than 1.4 million times.
  • But there's something about Sonny that sets him apart from the other kids – he was conceived through Assisted Reproductive Technology (ART) and IVF.

The Howard and Georgeanna Jones Foundation for Reproductive Medicine supports Alabama infertility patients

Retrieved on: 
Saturday, February 24, 2024
Ethics, Education, Infertility, Reproductive medicine, Physician, Assisted reproductive technology, IVF, Supreme Court of Alabama, Fertilisation, Patient, Policy, Heart, Science, Research, Partnership

VIRGINIA BEACH, Va., Feb. 23, 2024 /PRNewswire/ -- The Howard and Georgeanna Jones Foundation for Reproductive Medicine ("Jones Foundation") was founded by IVF pioneers Dr. Howard W. Jones, Jr. and Dr. Georgeanna S. Jones who established the first in vitro fertilization program in the United States, the Jones Institute for Reproductive Medicine, that was responsible for the first American born IVF baby in 1981, and training many of today's leaders in the field.

Key Points: 
  • VIRGINIA BEACH, Va., Feb. 23, 2024 /PRNewswire/ -- The Howard and Georgeanna Jones Foundation for Reproductive Medicine ("Jones Foundation") was founded by IVF pioneers Dr. Howard W. Jones, Jr. and Dr. Georgeanna S. Jones who established the first in vitro fertilization program in the United States, the Jones Institute for Reproductive Medicine, that was responsible for the first American born IVF baby in 1981, and training many of today's leaders in the field.
  • "The ruling directly threatens Alabama reproductive medicine and infertility physicians and their patients.
  • The IVF therapy patients need in order to have a baby may be eliminated in Alabama and jeopardized in other U.S. states.
  • We must speak out and support reproductive medicine physicians and scientists and, especially, their patients."

Calibre Scientific Expands Assisted Reproductive Technologies Portfolio With Strategic Acquisitions of Scopescreen and Microm UK Limited

Retrieved on: 
Monday, January 8, 2024
Assisted reproductive technology, IVF, Male, Infertility, Research, ART, Doctor of Philosophy, Fertility, Growth, Patient

LOS ANGELES, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisitions of Microm UK Limited and Scopescreen, LLC (dba Bioscreen) (“Scopescreen”), further solidifying its commitment to reproductive health and testing.

Key Points: 
  • LOS ANGELES, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisitions of Microm UK Limited and Scopescreen, LLC (dba Bioscreen) (“Scopescreen”), further solidifying its commitment to reproductive health and testing.
  • “Microm UK Limited has built a stellar reputation with both customers and suppliers throughout the decades,” said Leslie Stump and Karen Collins, Directors of Microm UK Limited.
  • “We are excited about the growth that Microm UK Limited will experience in the years ahead as part of Calibre Scientific.
  • “These strategic acquisitions align seamlessly with our vision of shaping the future of assisted reproductive technologies.

Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2023

Retrieved on: 
Monday, November 13, 2023
Sale, Acquisition, Research, ART, HTL, Needle, Trade Adjustment Assistance, IVF, Azerion Group N.V., Hand, Software, Growth, Assisted reproductive technology, TSX, Pharmaceutical industry, Video game

and TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and nine months ended September 30, 2023.

Key Points: 
  • and TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and nine months ended September 30, 2023.
  • David Wolf, President and Chief Executive Officer, of Hamilton Thorne Ltd. commented, “Sales grew 16% for the quarter while sales for the year were up 17%.
  • While some of this reduction is transient, with orders up for Q4, these trends have been impacting our business for some time; however, we expect we are likely reaching a bottom.
  • Constant currency sales as reported were up 12% for the quarter and 16% for the first nine months ended September 30, 2023.

Dr. David Adamson, Founder and CEO, ARC Fertility Expands Upon the Importance of Family-Forming Benefits for Employer-Sponsored Health Plans in New Book ‘Benefits Revolution’

Retrieved on: 
Monday, November 13, 2023
Managed Care, General Health, Professional Services, Family, Consumer, Health Insurance, Publishing, Parenting, Women, Communications, Human Resources, Practice Management, Health, World Health Organization, ART, WHO, Assisted reproductive technology, Patient, Stanford University, Infertility, Reproductive medicine, University, MD, NGO, ARC, Society, Human, Performance, Health insurance, Birth control, Amazon, Fertility

ARC Fertility , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, announces David Adamson, MD, founder and CEO, ARC Fertility, as a co-author in the new book Benefits Revolution: The Next Generation of Employer-Sponsored Healthcare .

Key Points: 
  • ARC Fertility , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, announces David Adamson, MD, founder and CEO, ARC Fertility, as a co-author in the new book Benefits Revolution: The Next Generation of Employer-Sponsored Healthcare .
  • Dr. Adamson outlines why employers should implement family-forming benefits into employee health plans, providing actionable steps benefits advisors can take to deliver better, more cost-effective outcomes for clients and patients.
  • “Most traditional corporate benefits have become irrelevant to today’s workforce, but family-forming benefits like fertility care and infertility treatments can improve employee satisfaction, enhance work performance and save employers money in the long run,” says Dr. Adamson.
  • Previously, Dr. Adamson was president of numerous professional organizations, including the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology.

Illume Fertility Announces Local Fertility Specialist Dr. Barry Witt to Join its Team of Board-Certified Fertility Doctors

Retrieved on: 
Tuesday, November 28, 2023
Yale University, Acupuncture, Medical director, ART, Yoga, Assisted reproductive technology, Patient, Multimedia, Montefiore Medical Center, IVF, ACOG, American College, Genetic testing, ASRM, Reproductive medicine, Montefiore, Fertility, Yale School of Medicine, Parent, Obstetrics, Society, Knowledge, Anton Carl Illum, Medical device, Birth control, Nursing, Gynaecology, Medicine

NORWALK, Conn. , Nov. 28, 2023 /PRNewswire-PRWeb/ -- Illume Fertility, a leading modern fertility practice whose experts help individuals and couples grow their families, has announced the addition of Barry Witt, M.D. to its award-winning team of board-certified reproductive endocrinologists serving Westchester and Fairfield Counties.

Key Points: 
  • "We are thrilled to have Dr. Witt joining our already robust team," said Dr. Mark Leondires, Founder and Medical Director at Illume Fertility.
  • "Dr. Witt brings with him a wealth of knowledge and experience, and will fit in wonderfully to our patient-centered care model."
  • "Dr. Witt brings with him a wealth of knowledge and experience, and will fit in wonderfully to our patient-centered care model."
  • "I am honored to join the talented team at Illume Fertility, and I look forward to continuing to serve both Westchester and Fairfield Counties with a high level of personalized, state-of-the-art care," says Dr. Barry Witt.

Hamilton Thorne to Announce Q3 2023 Financial Results and Hold Conference Call on November 13, 2023

Retrieved on: 
Tuesday, November 7, 2023
ART, Research, Conference, HTL, EDT, Assisted reproductive technology, TSX, Directory assistance, Software, Rare-earth element, Cryptocurrency, Video game

and TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and nine months ended September 30, 2023 before market open on Monday, November 13, 2023.

Key Points: 
  • and TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and nine months ended September 30, 2023 before market open on Monday, November 13, 2023.
  • The press release, with accompanying financial information, will be posted on the Company’s website at www.hamiltonthorne.ltd and on www.sedar.com .
  • The Company will follow with a conference call on the same day at 9:00 a.m. EDT to review highlights of the results.
  • All interested parties are welcome to join the conference call by dialing toll free 1-833-366-1126 in North America, or 1-412-317-0703 from other locations, and requesting the “Hamilton Thorne Conference Call.” The Company’s updated investor presentation and a recording of the call will be available on Hamilton Thorne’s website shortly after the call.

Clinics within The Prelude Network ® Recognized by the Society for Assisted Reproductive Technology for Excellence in Fertility Care Services and Reporting

Retrieved on: 
Tuesday, November 7, 2023
Science, American Society for Reproductive Medicine, SART, Fertility, Inception, RBA, Fertility clinic, Health, Society, ART, Reproductive medicine, IVF, Quality assurance, Dream, REI, Assisted reproductive technology, Partner, ASRM, Woman, Safety, Patient, Human Biology Association, Reproductive endocrinology and infertility, Parent, Birth control, Nursing

HOUSTON, Nov. 7, 2023 /PRNewswire/ -- The Prelude Network®, the largest network of fertility clinics in North America, announces today that two of its clinics have been recognized by the Society for Assisted Reproductive Technology (SART), with Reproductive Biology Associates (RBA) in Atlanta, Georgia receiving a SART Platinum designation and IVFMD in Miami, Florida receiving a SART Gold designation.

Key Points: 
  • HOUSTON, Nov. 7, 2023 /PRNewswire/ -- The Prelude Network ®, the largest network of fertility clinics in North America, announces today that two of its clinics have been recognized by the Society for Assisted Reproductive Technology (SART), with Reproductive Biology Associates (RBA) in Atlanta, Georgia receiving a SART Platinum designation and IVFMD in Miami, Florida receiving a SART Gold designation.
  • This recognition is a joint selection by SART's Quality Assurance and Validation Committees to recognize clinics for their excellence in prospective reporting and for following guidance set forth by the American Society for Reproductive Medicine (ASRM) and SART.
  • "It is a testament of their dedication to patients and the field of reproductive medicine to uphold, practice, and deliver the highest standards in fertility care."
  • The clinic provides patient-centric, individualized care that offers patients the latest science and technologies in fertility medicine.

Family Matters Fertility Centre Launches Innovative Fertility Tourism Program Welcoming Americans

Retrieved on: 
Friday, October 27, 2023
Knowledge, Female, Gynaecology, Education, Birmingham Women's Fertility Centre, System, Health, Bachelor of Medicine, Bachelor of Surgery, Hope, Family, Obstetrics, Endocrinology, HIV, HIV Clinical Resource, Bachelor, IVF, Transport, Dream, COVID-19, Freezing, Assisted reproductive technology, Police, Woman, Reproductive medicine, Safety, Anxiety, Infertility, Patient, Empathy, Parent, Birth control, Nursing

South Africa’s female-led fertility clinic, Family Matters Fertility Centre is distinguished by its first female-led approach, which is designed to meet the individual requirements and convenience of female patients.

Key Points: 
  • South Africa’s female-led fertility clinic, Family Matters Fertility Centre is distinguished by its first female-led approach, which is designed to meet the individual requirements and convenience of female patients.
  • Family Matters Fertility Centre's journey began in February 2020, just before the global COVID-19 pandemic took hold.
  • Family Matters Fertility Centre has launched ‘Fertility Tourist Program’ to cater to a wider audience.
  • Family Matters Fertility Centre is more than just a medical facility; it's a place where dreams of parenthood are fulfilled and hope transforms into joy, welcoming both American and international patients on their path to parenthood.